Entering text into the input field will update the search result below

BIOLASE, Inc. (BIOL) Q4 2022 Earnings Call Transcript

Mar. 28, 2023 9:31 PM ETBIOLASE, Inc. (BIOL)
SA Transcripts profile picture
SA Transcripts

BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET

Company Participants

Todd Kehrli - IR

John Beaver - President and CEO

Jennifer Bright - CFO

Conference Call Participants

Bruce Jackson - The Benchmark Company

Frank Takkinen - Lake Street Capital Markets

Anthony Vendetti - Maxim Group

Edward Woo - Ascendiant Capital


Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full Year Financial Results Call. [Operator Instructions] Please note, this conference is being recorded.

I will now turn the conference over to your host, Todd Kehrli of EVC Group. You may begin.

Todd Kehrli

Thank you, operator. Good afternoon, everyone, and thank you for joining us today to discuss BIOLASE's financial results for the fourth quarter and full year 2022 ended December 31, 2022. On the call today from BIOLASE are John Beaver, President and Chief Executive Officer; and Jennifer Bright, Chief Financial Officer. John will review the company's operating performance and then turn the call over to Jennifer to review the financials in more detail before opening the call for questions.

Before we begin, I'd like to remind everyone that a number of forward-looking statements, which are any statements that are not historical facts, will be made during this presentation and subsequent Q&A session, including forward-looking statements regarding the company's strategic initiatives and anticipated financial performance. These statements are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 and are based on BIOLASE's current expectations and assumptions and are subject to a variety of risks and uncertainties that could cause the company's actual results to differ materially from the statements made. Such forward-looking statements only represent the company's view as of today, March 28, 2023. These risks are discussed in the Risk Factors section of the company's most recent Form 10-K filed with the Securities and Exchange Commission. A

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.